Sree Rayalaseema Hi-Strength Hypo
Sree Rayalaseema Hi-Strength Hypo (SRHHYPOLTD) share price was ₹474.00 at the 28 Oct 2026 close; market capitalisation ₹814 Cr; P/E (TTM) 8.90; sector Chemicals. The share price fell 14.5% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 17.0% year on year to ₹210.9 Cr and net profit rose 10.3% year on year to ₹24.7 Cr (compared with Jun 2025). Promoters held 62.19% of Sree Rayalaseema Hi-Strength Hypo in Sep 2026, up 0.35 percentage points from Jun 2026. Its Tapetide Score is 65/100 (Good) as of 28 Oct 2026.
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of 29 Oct 2026, 10:46 IST · EPS basis: Consolidated · TTM
Peer Comparison
Commodities › Chemicals › Commodity Chemicals
| ₹2,353.50 | 32.27 | 69,764 Cr | 4.56 | 0.21% | 13.07% | 14.64% | 17,997 Cr | 2,162 Cr | |
| ₹605.00 | — | 15,413 Cr | 0.73 | 1.84% | -7.73% | -2.69% | 15,521 Cr | -1,971 Cr | |
| ₹1,176.10 | 15.09 | 14,847 Cr | 2.17 | 0.84% | 9.90% | 11.30% | 12,189 Cr | 984 Cr | |
| ₹515.30 | 7.30 | 7,572 Cr | 0.83 | 4.12% | 8.75% | 10.38% | 8,860 Cr | 1,037 Cr | |
| — | 103.79 | 7,489 Cr | 10.36 | 0.13% | 18.80% | 25.38% | 725 Cr | 68 Cr | |
| ₹552.05 | 61.07 | 4,055 Cr | 0.78 | 3.20% | -0.05% | 1.29% | 4,622 Cr | 66 Cr | |
| ₹386.70 | 7.70 | 3,563 Cr | 1.00 | 3.04% | 13.30% | 16.87% | 3,138 Cr | 473 Cr | |
| ₹486.55 | 9.14 | 835 Cr | 0.86 | 0.62% | 9.16% | 11.64% | 752 Cr | 92 Cr | |
| Median 8 companies | ₹552.05 | 15.09 | 7,530 Cr | 0.93 | 1.34% | 9.53% | 11.47% | 6,741 Cr | 283 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 100/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.92 times its book value
Weaknesses
4- The company has delivered a poor sales growth of -6.04% over past five years.
- Company has a low return on equity of 10.8% over last 3 years.
- Earnings include an other income of Rs.45.2 Cr.
- Dividend payout has been low at 5.95% of profits over last 3 years
Technical Indicators
Oscillators
Bullish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 14% · Jun 2026
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 261 | 226 | 215 | 165 | 169 | 170 | 138 | 160 | 180 | 182 | 141 | 163 | 211 |
| Expenses | 226 | 199 | 192 | 138 | 143 | 141 | 119 | 143 | 152 | 155 | 124 | 150 | 181 |
| Operating Profit | 35 | 26 | 22 | 27 | 26 | 29 | 20 | 18 | 28 | 27 | 17 | 13 | 30 |
| OPM % | 13% | 12% | 10% | 16% | 15% | 17% | 14% | 11% | 15% | 15% | 12% | 8% | 14% |
| Other Income | 1 | 2 | 4 | 4 | 2 | 9 | 13 | 12 | 6 | 7 | 19 | 12 | 6 |
| Interest | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| PBT | 33 | 25 | 23 | 26 | 26 | 36 | 30 | 27 | 31 | 32 | 34 | 23 | 34 |
| Tax % | 26% | 27% | 29% | 24% | 28% | 29% | 29% | 19% | 28% | 27% | 31% | 14% | 27% |
| Net Profit | 24 | 18 | 17 | 20 | 19 | 25 | 22 | 22 | 22 | 23 | 24 | 20 | 25 |
| EPS (₹) | 14.16 | 10.77 | 9.69 | 11.39 | 10.85 | 14.74 | 12.56 | 12.81 | 12.77 | 13.57 | 13.84 | 11.54 | 14.28 |
Profit & Loss
| Particulars | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 362 | 164 | 689 | 911 | 1,267 | 1,650 | 866 | 638 | 667 | 698 |
| Expenses | 318 | 142 | 587 | 781 | 1,119 | 1,470 | 755 | 546 | 578 | 610 |
| Operating Profit | 44 | 22 | 102 | 130 | 149 | 180 | 111 | 92 | 88 | 87 |
| OPM % | 12% | 13% | 15% | 14% | 12% | 11% | 13% | 14% | 13% | 12% |
| Other Income | 2 | 0 | 4 | 7 | 11 | 34 | 11 | 36 | 41 | 45 |
| Interest | 11 | 3 | 10 | 5 | 3 | 5 | 4 | 2 | 2 | 2 |
| Depreciation | 10 | 10 | 50 | 51 | 19 | 19 | 11 | 7 | 7 | 7 |
| PBT | 25 | 9 | 45 | 81 | 137 | 190 | 107 | 119 | 121 | 123 |
| Tax % | 27% | -1% | 17% | 25% | 25% | 19% | 26% | 27% | 25% | — |
| Net Profit | 25 | 9 | 38 | 61 | 103 | 154 | 79 | 87 | 90 | 92 |
| EPS (₹) | 17.02 | 5.64 | 22.09 | 35.29 | 59.88 | 89.86 | 46.06 | 52.47 | 53.25 | 53.23 |
| Div. Payout % | 9% | 25% | 11% | 8% | 6% | 4% | 7% | 6% | 6% | — |
Balance Sheet
| Particulars | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15 | 15 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves | 189 | 182 | 294 | 371 | 553 | 734 | 783 | 901 | 954 |
| Borrowings | 85 | 79 | 57 | 72 | 28 | 19 | 13 | 16 | 12 |
| Other Liabilities | 84 | 64 | 76 | 59 | 189 | 175 | 100 | 136 | 133 |
| Total Liabilities | 372 | 340 | 445 | 519 | 788 | 945 | 914 | 1,070 | 1,115 |
| Fixed Assets | 195 | 187 | 161 | 134 | 130 | 105 | 128 | 135 | 132 |
| CWIP | 2 | 0 | 3 | 0 | 0 | 14 | 0 | 0 | 0 |
| Investments | 39 | 23 | 18 | 50 | 164 | 268 | 253 | 349 | 307 |
| Other Assets | 137 | 129 | 262 | 334 | 494 | 558 | 534 | 585 | 677 |
| Total Assets | 372 | 340 | 445 | 519 | 788 | 945 | 914 | 1,070 | 1,115 |
Cash Flow
| Particulars | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Operating | 21 | -8 | 99 | 71 | 60 | 141 | 140 | 65 | 39 |
| Investing | -9 | -1 | -38 | -115 | -1 | -112 | -20 | -8 | 37 |
| Financing | -12 | 11 | -22 | 10 | -51 | -17 | -17 | -18 | -11 |
| Net Cash Flow | 0 | 2 | 40 | -35 | 7 | 13 | 103 | 40 | 65 |
| Free Cash Flow | 14 | -9 | 91 | 50 | 45 | 133 | 120 | 63 | 38 |
| CFO/EBITDA | 63 | -35 | 108 | 82 | 62 | 122 | 152 | 105 | 74 |
Ratios
| Particulars | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54 | 117 | 43 | 39 | 38 | 33 | 45 | 59 | 46 |
| Inventory Days | 37 | 49 | 36 | 27 | 62 | 39 | 24 | 50 | 55 |
| Days Payable | 39 | 16 | 24 | 8 | 33 | 22 | 10 | 18 | 13 |
| Cash Conversion Cycle | 51 | 150 | 55 | 57 | 67 | 50 | 59 | 91 | 88 |
| Working Capital Days | -2 | 53 | 24 | 23 | 47 | 42 | 59 | 82 | 86 |
| ROCE % | — | 4% | — | 21% | 26% | 26% | 15% | 14% | 14% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Sree Rayalaseema Hi-Strength Hypo insights
65 extracted metrics + investor summaries across FY12–FY27.
Documents
Frequently Asked Questions about Sree Rayalaseema Hi-Strength Hypo
What does Sree Rayalaseema Hi-Strength Hypo Ltd do?
Where is Sree Rayalaseema Hi-Strength Hypo Ltd (SRHHYPOLTD) listed?
Which sector does Sree Rayalaseema Hi-Strength Hypo Ltd belong to?
What is the market capitalisation of Sree Rayalaseema Hi-Strength Hypo Ltd?
What is the PE ratio of Sree Rayalaseema Hi-Strength Hypo Ltd?
What is the 52-week high and low of Sree Rayalaseema Hi-Strength Hypo Ltd?
Does Sree Rayalaseema Hi-Strength Hypo Ltd pay dividends?
What is the Return on Equity (ROE) of Sree Rayalaseema Hi-Strength Hypo Ltd?
Company Information
Incorporated in 2005, Sree Rayalaseema Hi – Strength Hypo Ltd is a producer of producer of Calcium Hypo -chloride, Stable Bleaching Powder, Sulphuric Acid and other chemicals[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SRHHYPOLTD.md for Sree Rayalaseema Hi-Strength Hypo Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.